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Abstract  
Introduction: there has been an increasing rate of the incidence and mortality of cervical cancer in Ghana. Cancer and the treatment's side effects 
have adverse effects on the patients and this affects patient's well-being and lifestyle during and after radiotherapy. The study sought to assess the 
impact of demographic and clinical characteristics on Quality of Life (QoL) among cervical cancer patients undergoing radiotherapy in Ghana. 
Methods: a cross sectional quantitative study design was carried out on 120 cervical cancer patients who were conveniently sampled from the study 
site. The data was collected between the months of December, 2017 and February, 2018. QoL was measured using the FACT-G questionnaire. The 
mean scores of QoL were determined, whiles the chi-square test was used to determine the impact of socio-demographic and clinical characteristics 
on the QoL of the patients. Results: the mean age of the patients was 56.8 years. Majority of the patients reported stable QoL. The social  
well-being of the older patients was more affected than other patients. The unmarried, widows and patients who underwent surgery with radiotherapy 
were emotionally affected. Majority (56%) of the participants had stable QoL whiles 22% each had poor and good QoL. Significant association was 
found among 35-39 age group with physical well-being and overall QoL (p=0.017 and 0.029) respectively. Conclusion: there is a need to embrace 
a QoL assessment instrument in the study site so as to help the oncology team in the identification and addressing of specific indicators that affect 
the QoL of cervical cancer patients. 
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It is imperative to improve the quality of life of cervical cancer patients 
in low and middle income countries. Of the 279 thousand global 
cervical cancer deaths in 2015, 85% occurred in low and middle 
income countries (LMICs) [1]. Annually, cervical cancer accounts for 
8.9 million disability-adjusted life years (DALYs), making it one of the 
leading causes of years lived with disability in LMICs [1]. Like other 
LMICs, the mortality burden of cervical cancer in Ghana is significantly 
increasing. In the absence of a formal cancer registry in 2012, it was 
estimated that 3052 new cases of cervical cancer were diagnosed in 
Ghana, with more than 50% deaths annually [2]. This morbidity and 
mortality burdens are expected to increase to 5,000 new cases of 
cervical cancer and 67.2 annual mortality rates. However, this growing 
burden can be prevented or reduced by investing the cost-effective 
and quality improvement strategies related to prevention, early 
detection, diagnosis, treatment (surgery, radiotherapy and essential 
cancer medicines), survivorship and palliative care [3]. Studies have 
been published concerning the health of Ghanaian cervical cancer 
patients and survivors [4-8] and these focused on the prevention, 
screening and population´s knowledge of the disease. 
 
However, none of these studies has shown the effect of treatment on 
the QoL of cervical cancer patients. This introduces a gap in literature 
hence within the protocols in cancer treatment procedures especially 
cervical cancer. Apart from the gap in literature in Ghana, studies from 
other settings have indicated other contradicting outcomes with 
QoL [9,10]. A study done in Thai, showed that the emotional  
well-being of cervical cancer patients were influenced by age due to 
the mentality of life after death by the older ones [9]. The Thai cervical 
cancer patients experienced low anxiety about death; hence older 
women achieved high QoL. However, a similar study conducted by 
Miller et al. [10] in America reported contradicting outcome among 
the cervical cancer patients. In addition to the above studies, findings 
from a qualitative study conducted by Ashing-Giwa, Lim and 
Gonzalez [11] revealed significant association between the physical 
well-being and ethnicity. Hence, socio-demographic variables like race 
and cultural beliefs is seen to play a critical role in the setting protocols 
and treatment procedures for patients undergoing radiotherapy [12]. 
The study was aimed to assess impact of demographic and clinical 
characteristics on QoL of Ghanaian cervical cancer patients 





A cross sectional quantitative study design was used in this study 
using clinically diagnosed cervical cancer patients undergoing 
radiotherapy at the study site. The study took place at the main 
Oncology Centre in Accra, Ghana between the months of December, 
2017 and February, 2018. The centre was chosen for the study 
because it serves a total of 70% of all cancer cases seen in the country 
according to Kyei et al. [13]. One hundred and twenty cervical cancer 
patients were recruited for the study using a convenient sampling 
method [14]. The study included cervical cancer patients undergoing 
radiotherapy, with or without other treatment modalities such as 
chemotherapy, surgery and hormonal therapy. Patients who 
consented to participate in the study were selected. Non-Ghanaians 
undergoing cervical cancer treatment were excluded because of the 
difficulties in language barriers. Out of the 120 cervical cancer patients 
who took part in the study, none of them requested for withdrawal 
during the administration of questionnaire. FACT-G questionnaires 
were administered to the patients as it produced results which were 
reproducible for this type of study [15]. 
 
The questionnaires were made available to patients in English 
because, it is the only official language in Ghana. Quantitative data 
collected from the study was uploaded into a computerized database 
using Statistical Package for Social Sciences (SPSS) version 20.0. 
Descriptive statistics was used to analyze the socio-demographic 
characteristics such as age, level of education, marital status, clinical 
characteristics including the treatment modalities and stages of cancer 
as well as the QoL scores. Chi-square was used to determine the 
existence of association between socio-demographic and clinical 
characteristics with QoL. A p-value of 0.05 was used to define the 
chosen level of statistical significance. A Pearson´s chi-square with p-
value less than 0.05 (p<0.05) signals significant difference between 
the variables and p-value equal or more than 0.05 (p≥0.05) indicates 
no significant difference between the variables. Confidentiality of all 
the information provided by the participants was ensured throughout 
collection and storage of data. Ethical approval was sought and 
obtained from the Ethics and Protocol Review Committee of a higher 
institution and the head of department of the study site before data 
collection. Consent was sought and obtained from all the 120 patients 
who took part in the study. 
 
 





In all, 120 patients were recruited to participate in the study after 
consent and 100% response rate was achieved. Ages of participants 
ranged from 36 years to 76 years and majority of the participants, 
24.2% (n=29) were within the age range of 55 years to 59 years. 
In Table 1, 42.5% (n=51) had no formal education, while 10% (n=12) 
attained higher education level. Almost 66% (n=79) were married 
while 4.2% (n=5) were single. As shown in Table 2, 44.2% (n=53) 
had stage III and only 2.5% (n=3) presented with stage I. Seventy 
percent (n=84) had combination of chemotherapy and radiotherapy 
where as 15.3% (n=19) had triple treatment modalities (surgery, 
chemotherapy and radiotherapy). The assessment of the QoL of the 
participants was determined using FACT-G questionnaire. For the 
purpose of this study, these initials were used: PWB- physical well-
being, SWB- social well-being, EMB- emotional well-being, FWB- 
Functional well-being, and OQoL- grand quality of life. 
 
With the exception of social well-being in which 50-54 age group 
scored the highest mean score (19.0 ± 5.2), participants in the 35-37 
age group scored highest mean scores in all the QoL items including 
OQoL mean score (Table 3). In the case of level of education, 
participants in the tertiary category scored the highest physical 
(19 ± 5.1), social (18.4 ± 5.3), emotional (17.2 ± 5.8), functional 
(21.6 ± 4.3) and overall QoL (76.6 ± 17.4) mean scores. Participants 
in the non-formal education category scored least in all the scores 
(Table 3). Married women scored the highest mean scores in all 
categories whiles the unmarried women scored least in the category 
of physical (9.5 ± 3.5) and emotional (5.0 ± 5.7) well-being and 
overall QoL (41.5 ± 7.8) mean scores (Table 3). In Table 4, treatment 
modalities were presented. Participants who went through 
combination of chemotherapy and radiotherapy scored the highest 
mean scores in physical (13.4 ± 5.9), functional, well-being 
(13.7 ± 5.3) and OQoL (55.5 ± 18.7). The highest mean scores were 
found among participants with stage II. Participants with stage IV had 





It was evident from the study that incidence of cervical cancer 
increased with age and then dropped at a peak of 55 to 59 year group. 
In terms of knowledge about the cancer disease and its preventive 
measures in Africa, the younger women are better placed than the 
older women due to the current ongoing education and public 
awareness in the country. This was consistent with other studies 
conducted in other parts of Ghana and also in Kenya, where authors 
commented that, cervical cancer was prevalent among age group of 
premenopausal to menopausal women [16,17]. This study further 
affirms that cervical cancer was not dominant among the younger 
participants unlike breast cancers [13]. 
 
Impact of demographic and clinical characteristics on QoL 
 
Physical well-being: according to the findings of the study, the 
physical well-being of cervical cancer patients was affected by their 
age and the level of education (Table 3). It was identified that the 
majority had no formal education. This was significant in identifying 
whether or not their interpretations of their condition and the effect 
of treatment was spot-on. Again, the findings might be due to the 
attention and worry of the younger and the educated patients on the 
side effects of the treatment. In effect, one´s level of education and 
their age could influence their overall outlook and this was in line with 
a study by Ashing-Giwa et al. [11] where their findings suggested a 
significant association between level of education and physical well-
being among breast and cervical cancer patients. 
 
Social well-being: this study reported no significant association 
between the treatment modalities and the social well-being of the 
patients (Table 3). Hence, the kind of treatment did not suggestively 
affect the socio-familial life of the patients. However, a study by 
Frumovitz et al. [18] found that sexual dysfunction significantly 
affected the social life of the participants in their study. Furthermore, 
another study showed that patients with physical changes such as 
fatigue, hair loss, darkening of skin and weight loss as a result of side 
effect of their treatment had their social lives affected [19]. Therefore, 
the consequences of the physical changes could be stigmatization, 
isolation from social milieu and loneliness [20]. 
 
Emotional well-being: emotionally, married women scored higher 
in terms of mean score than unmarried women (Table 3). The 
presence of spouse or partners played a role in the well-being of the 
patients emotionally. This study reported significant association 
between marital status and emotion of the patients. Specifically, 
emotional impact was found among patients who were single and 
widowed, thus these findings could be due to the absence of partners 
to occupy periods of loneliness and also assist in re-assurance during 
the treatment. Despite high emotional well-being score among 
patients with early staged cancer, stage of the cancer did not have 
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any significant effect on emotional well-being of the patients in this 
setting. To support this finding, Pasek et al. [21] also reported no 
significant association between emotional well-being and cancer 
stage. In consistent with the current study, Baze et al. [22] reported 
that, due to the severity of the disease, poor emotional scores were 
recorded among advanced cancer staged patients. Meanwhile, 
Azmawati et al. [23] reported high emotional well-being scores among 
patients with advanced stage of cancer. The current study revealed 
significant association between treatment modalities and emotional 
well-being. Additionally, patients who underwent combination of 
surgery and radiotherapy were likely to face more emotional impact 
compared to other groups (Table 4). Thus, Perrin et al. [24] stipulated 
feelings of fear, hopelessness, anger, shock and self-blame as the 
outcomes of physical changes as a result of the treatment. However, 
Frumovit et al. [18] reported better emotional well-being among 
patients treated with surgery only compared to those treated with 
radiotherapy only. Krikeli et al. [25] revealed that emotional well-
being had no significant impact on the patients no matter the kind of 
treatment the patient underwent. 
 
Functional well-being: patients within the age range of 50 to 54 
years had significant impact on their functional well-being (Table 3). 
In concord with the current study, Greimel et al. [26] reported no 
significant difference among all their age groups. The study reported 
significant association between patients with cancer stage II and 
functional well-being (Table 4). This by implication means only 
patients with cancer stage II are likely to be affected functionally. 
Patients who underwent chemotherapy and radiotherapy were 
functionally stronger and had no statistically significant association 
between the kind of treatment and functional well-being. Hence, the 
functional well-being had no effect on the kind of treatment the 
patients underwent. In contrast, Greimel et al. [26] reported 
contradicting outcome on functional well-being. 
 
Overall quality of life: early staged cancer patients reported with 
higher overall QoL scores than those with late presentation of the 
disease. The finding of the current study was in accordance with that 
of other studies [23-25]. There was no statistically significant 
relationship between the forms of treatment received by patients and 
their overall QoL. Thence, patients were unlikely to be significantly 
affected by the kind of treatment they underwent. The current study 
was consistent with another similar study [27]. Yet, other contrary 
findings were present in another similar study [18]. Also, no significant 
association was found between cancer stage and overall QoL of the 
patients. Hence, irrespective of the stage of the disease, patients were 
not functionally retarded. However, contradicting findings were 
present in other studies reported by Ogoncho et al. [17]. The 
difference in outcomes could be due to the differences in the 
presentation of the disease. Usually, the developing countries 
presents with late cancer stage compared to the early stage 





The findings of this study showed that, majority of cervical cancer 
patients receiving treatment at the study site had stable QoL. While 
younger patients were likely to be affected physically during the 
course of the treatment, functional challenges were possible among 
menopausal patients and socio-familial challenges among older 
patients. During the course of the treatment, stage II cervical cancer 
patients were likely to be affected functionally. Hence, some socio-
demographic and clinical characteristics were likely to affect the QoL 
of the patients. There is a need to embrace a QoL assessment 
instrument at the study site so as to help the oncology team in the 
identification and addressing of specific indicators that affect the QoL 
of cervical cancer patients. 
 
What is known about this topic 
• A study conducted among Ghanaian cervical cancer patients 
reported 64% presenting with advanced stage of the 
disease; 
• Reports indicate that older cervical patients who are 
unmarried have positive correlation with QoL; 
• Higher levels of education correlate with higher QoL and the 
differences are clear in the social and functional domain. 
What this study adds 
• Cervical cancer is not dominant among the younger age 
grouped below 35 years; 
• Education and age affected the physical well-being of 
cervical cancer patients; 
• Early cervical cancer patients reported with higher overall 
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Table 1: demographic and clinical data (n=120) 
Variables Categories Frequency (%) 
Age 35-39 6 (5.0) 
  40-44 15 (12.5) 
  45-49 25 (20.8) 
  50-54 21 (17.5) 
  54-59 29 (24.2) 
  60-64 9 (7.5) 
  65-69 10 (8.3) 
  70-74 3 (2.5) 
  75-79 2 (1.7) 
Education Elementary 22 (18.3) 
  Middle school 16 (13.3) 
  Secondary 19 (15.9) 
  Higher education 12 (10.0) 
  No formal education 51 (42.5) 
Marital Status Single 5 (4.2) 
  Married 79 (65.8) 
  Divorced 26 (21.7) 
  Widow 10 (8.3) 
The majority of participants were between the ages of 54-59. The 
majority (42.5%) had no formal education. 65.8% were married during 






















Table 2: clinical characteristics of patients n=120 
Variables Categories Frequency (%) 
Cancer Stage  Stage I 3 (2.5) 
  Stage II 41 (34.2) 
  Stage III 53 (44.2) 
  Stage IV 23 (19.1) 
Treatment Modalities Radiotherapy only 14 (11.7) 
  Radiotherapy & Chemotherapy only 84 (70.0) 
  Radiotherapy & Surgery 3 (2.5) 
  Radiotherapy, Chemotherapy & Surgery 19 (15.3) 
The majority (63.3%) had stages three and beyond, with 70% of the patients undergoing a 
combination of chemotherapy and radiotherapy. 
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Table 3: mean and Pearson’s Chi-square P-value of participants’ quality of life 















Age (n)           
35-39 (6) 22.0 (0.017) 17.0 (0.947) 21.5 (0.063) 21.5 (0.198) 82.0 (0.029) 
40-44 (15) 16.4 (0.166) 17.0 (0.763) 12.2 (0.493) 15.8 (0.088) 61.4 (0.636) 
45-49 (25) 16.2 (0.336) 18.6 (0.490) 13.8 (0.890) 13.4 (0.920) 62.0 (0.636) 
50-54 (21) 15.5 (0.097) 19.0 (0.101) 16.0 (0.112) 19 (0.003) 71.3 (0.539) 
55-59 (29) 11.1 (0.714) 14.5 (0.443) 12.4 (0.778) 12.6 (0.611) 51.5 (0.539) 
60-64 (9) 10.0 (0.331) 11.8 (0.332) 11.2 (0.224) 11.3 (0.167) 42.1 (0.228) 
65-69 (10) 10.7 (0.826) 14.6 (0.787) 10.4 (0.583) 9.9 (0.318) 45.7 (0.323) 
70-74 (3) 12.0 (0.845) 14.3 (0.629) 12.7 (0.621) 12.3 (0.751) 51.2 (0.651) 
75-79 (2) 8.0 (0.176) 7.5 (0.003) 7.5 (0.991) 6.5 (0.560) 29.5 (0.029) 
Education (n)           
Elementary (22) 13.4 (0.954) 16.4 (0.866) 14.2 (0.728) 13.1 (0.497) 57.2 (0.609) 
Middle School (16) 14.7 (0.703) 14.7 (0.593) 12.7 (0.443) 14.1 (0.539) 56.3 (0.485) 
Secondary (19) 13.6 (0.136) 16.4 (0.308) 11.4 (0.122) 13.1 (0.705) 54.5 (0.185) 
Higher education (12) 19.4 (0.049) 18.4 (0.391) 17.2 (0.094) 21.6 (0.002) 76.6 (0.122) 
No formal education (51) 10.0 (0.219) 13.2 (0.856) 11.3 (0.455) 11.1 (0.030) 45.7 (0.263) 
Marital Status (n)           
Unmarried (5) 9.5 (0.997) 15.0 (0.424) 5.0 (0.037) 12.0 (0.961) 41.5 (0.968) 
Married (79) 14.1 (0.623) 15.9 (0.515) 14.2 (0.269) 14.5 (0.431) 58.0 (0.508) 
Divorced (26) 10.2 (0.730) 12.6 (0.614) 10.4 (0.203) 10.0 (0.361) 45.1 (0.313) 
Widow (10) 11.0 (0.505) 14.8 (0.803) 10.0 (0.014) 12.8 (0.960) 48.3 (0.412) 




Table 4: quality of life with cancer stages and treatment modalities (n=120) 















Stages (n)           
Stage I (3) 16.0 (0.770) 17.0 (0.816) 18.0 (0.925) 14.0 (0.897) 65.0 (0.858) 
Stage II (41) 16.9 (0.440) 17.6 (0.318) 15.7 (0.197) 17.3 (0.021) 67.5 (0.400) 
Stage III (53) 11.6 (0.512) 14.4 (0.121) 12.4 (0.888) 11.6 (0.518) 49.5 (0.310) 
Stage IV (23) 8.1 (0.249) 12.0 (0.050) 7.5 (0.204) 10.0 (0.761) 38.7 (0.554) 
Treatment Modalities (n)           
Radiotherapy only (14) 12.9 (0.569) 14.1 (0.233) 13.3 (0.201) 13.4 (0.188) 53.5 (23.6) 
Radiotherapy & 
Chemotherapy  (84) 
13.4 (0.800) 15.5 (0.176) 13.2 (0.409) 13.7 (0.602) 55.5 (0.485) 
Surgery + Radiotherapy (3) 12.0 (1.000) 18.0 (0.816) 5.0 (0.000) 12.0 (0.897) 47.0 (0.994) 
Radiotherapy, Chemotherapy 
& Surgery (19) 
9.3 (0.601) 12.8 (0.575) 9.8 (0.851) 11.0 (0.754) 44.8 (0.220) 
A strong evidence of association was indicated between participants who underwent surgery and radiotherapy and emotional well-being (p= 
0.000). 
 
 
 
 
